Aull & Monroe Investment Management Corp Amgen Inc Transaction History

Aull & Monroe Investment Management Corp

$202 Million
Q2 2024

A detailed history of Aull & Monroe Investment Management Corp transactions in Amgen Inc stock. As of the latest transaction made, Aull & Monroe Investment Management Corp holds 11,315 shares of AMGN stock, worth $3.62 Million. This represents 1.75% of its overall portfolio holdings.

Number of Shares

11,315

Previous 11,990 5.63%

Holding current value

$3.62 Million

Previous $3.41 Million 3.73%

% of portfolio

1.75%

Previous 1.57%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$262.75 - $319.31 $177,356 - $215,534	-675 Reduced 5.63%	11,315 $3.54 Million
Q1 2024 May 06, 2024	SELL	$268.87 - $324.56 $120,991 - $146,052	-450 Reduced 3.62%	11,990 $3.41 Million
Q4 2023 Jan 25, 2024	SELL	$255.7 - $288.46 $57,276 - $64,615	-224 Reduced 1.77%	12,440 $3.58 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $32,797 - $40,719	-150 Reduced 1.17%	12,664 $3.4 Million
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $45,158 - $55,040	-200 Reduced 1.54%	12,814 $3.1 Million
Q4 2022 Feb 07, 2023	SELL	$229.03 - $291.01 $112,224 - $142,594	-490 Reduced 3.63%	13,014 $3.42 Million
Q2 2022 Aug 08, 2022	SELL	$230.71 - $256.74 $25,378 - $28,241	-110 Reduced 0.81%	13,504 $3.29 Million
Q1 2022 May 02, 2022	BUY	$219.27 - $242.57 $43,854 - $48,514	200 Added 1.49%	13,614 $3.29 Million
Q4 2021 Feb 02, 2022	SELL	$198.88 - $227.6 $49,720 - $56,900	-250 Reduced 1.83%	13,414 $3.02 Million
Q3 2021 Oct 26, 2021	SELL	$212.27 - $248.7 $11,038 - $12,932	-52 Reduced 0.38%	13,664 $2.91 Million
Q1 2021 Apr 19, 2021	SELL	$221.91 - $258.6 $63,244 - $73,701	-285 Reduced 2.04%	13,716 $3.41 Million
Q4 2020 Feb 02, 2021	BUY	$216.38 - $257.67 $64,048 - $76,270	296 Added 2.16%	14,001 $3.22 Million
Q2 2020 Jul 28, 2020	SELL	$197.81 - $242.74 $138,467 - $169,918	-700 Reduced 4.86%	13,705 $3.23 Million
Q1 2020 Apr 22, 2020	BUY	$182.24 - $241.7 $13,668 - $18,127	75 Added 0.52%	14,405 $2.92 Million
Q4 2019 Feb 04, 2020	SELL	$189.21 - $243.2 $18,921 - $24,320	-100 Reduced 0.69%	14,330 $3.46 Million
Q3 2019 Oct 30, 2019	SELL	$174.11 - $208.62 $8,705 - $10,431	-50 Reduced 0.35%	14,430 $2.79 Million
Q2 2019 Jul 29, 2019	BUY	$166.7 - $195.41 $92,518 - $108,452	555 Added 3.99%	14,480 $2.67 Million
Q1 2019 Apr 18, 2019	SELL	$180.87 - $203.88 $144,696 - $163,104	-800 Reduced 5.43%	13,925 $2.65 Million
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $103,828 - $121,201	-582 Reduced 3.8%	14,725 $2.87 Million
Q3 2018 Oct 31, 2018	SELL	$185.29 - $208.89 $4,632 - $5,222	-25 Reduced 0.16%	15,307 $3.17 Million
Q2 2018 Jul 24, 2018	BUY	$166.05 - $186.51 $344,553 - $387,008	2,075 Added 15.65%	15,332 $2.83 Million
Q4 2017 Jan 29, 2018	SELL	$168.79 - $188.59 $67,516 - $75,436	-400 Reduced 2.93%	13,257 $2.31 Million
Q3 2017 Oct 26, 2017	SELL	$167.29 - $191.0 $25,093 - $28,650	-150 Reduced 1.09%	13,657 $2.55 Million
Q2 2017 Aug 14, 2017	BUY	N/A	13,807	13,807 $2.38 Million

Others Institutions Holding AMGN

# of Institutions

3,055

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aull & Monroe Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Aull & Monroe Investment Management Corp with notifications on news.

Account

Aull & Monroe Investment Management Corp Amgen Inc Transaction History